S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Conduit Pharmaceuticals (CDT) Short Interest Ratio & Short Volume

$3.12
+0.13 (+4.35%)
(As of 04/19/2024 ET)

Conduit Pharmaceuticals Short Interest Data

Current Short Volume
55,100 shares
Previous Short Volume
77,800 shares
Change Vs. Previous Month
-29.18%
Dollar Volume Sold Short
$202,217.00
Short Interest Ratio / Days to Cover
1.4
Last Record Date
March 31, 2024
Outstanding Shares
72,810,000 shares
Float Size
10,340,000 shares
Short Percent of Float
0.53%
Today's Trading Volume
13,045 shares
Average Trading Volume
22,857 shares
Today's Volume Vs. Average
57%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Conduit Pharmaceuticals ?

Sign up to receive the latest short interest report for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CDT Short Interest Over Time

CDT Days to Cover Over Time

CDT Percentage of Float Shorted Over Time

Conduit Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202455,100 shares $202,217.00 -29.2%0.5%1.4 $3.67
3/15/202477,800 shares $274,634.00 +12.8%0.8%1.8 $3.53
2/29/202469,000 shares $177,330.00 -39.1%0.7%0.7 $2.57
2/15/2024113,300 shares $345,565.00 -13.2%1.1%0.8 $3.05
1/31/2024130,500 shares $341,910.00 No Change1.3%0.9 $2.62

CDT Short Interest - Frequently Asked Questions

What is Conduit Pharmaceuticals' current short interest?

Short interest is the volume of Conduit Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 55,100 shares of CDT short. 0.53% of Conduit Pharmaceuticals' shares are currently sold short. Learn More on Conduit Pharmaceuticals' current short interest.

What is a good short interest ratio for Conduit Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDT shares currently have a short interest ratio of 1.0. Learn More on Conduit Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Conduit Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of Conduit Pharmaceuticals' floating shares are currently sold short.

Is Conduit Pharmaceuticals' short interest increasing or decreasing?

Conduit Pharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 55,100 shares, a decline of 29.2% from the previous total of 77,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Conduit Pharmaceuticals' float size?

Conduit Pharmaceuticals currently has issued a total of 72,810,000 shares. Some of Conduit Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Conduit Pharmaceuticals currently has a public float of 10,340,000 shares.

How does Conduit Pharmaceuticals' short interest compare to its competitors?

0.53% of Conduit Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Conduit Pharmaceuticals: Nektar Therapeutics (1.32%), Galectin Therapeutics Inc. (5.31%), Werewolf Therapeutics, Inc. (1.61%), Gossamer Bio, Inc. (4.77%), 23andMe Holding Co. (11.72%), Immutep Limited (1.43%), Ovid Therapeutics Inc. (4.78%), Organigram Holdings Inc. (5.43%), uniQure (5.83%), G1 Therapeutics, Inc. (5.28%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Conduit Pharmaceuticals stock?

Short selling CDT is an investing strategy that aims to generate trading profit from Conduit Pharmaceuticals as its price is falling. CDT shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Conduit Pharmaceuticals?

A short squeeze for Conduit Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDT, which in turn drives the price of the stock up even further.

How often is Conduit Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDT, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CDT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners